141st APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Recorded Annual Meeting Presentations (RAMP) are now available for purchase.
Only $90 for presenters, $140 for registered attendees and $200 for non-attendees.

Online Program

294743
Working with treatment and recovery partners


Tuesday, November 5, 2013 : 5:10 p.m. - 5:30 p.m.

Terry Cline, PhD, State Department of Public Health, State of Oklahoma, Oklahoma City, OK
     
Oklahoma was one of five states working with the Association of State and Territorial Health Officials (ASTHO) to develop a state learning community model to address prescription drug overdose misuse, abuse and diversion. The learning community model addresses prevention, monitoring, enforcement, treatment and recovery as issues that states should act upon comprehensively rather than in silos. Working with state public health agencies and partners across all sectors. The ASTHO state health policy and practice recommendations matrix developed from the White House ONDCP and CDC national guidelines were used to develop and implement a comprehensive action plan. In Oklahoma, by collaborating with state partners, a state task force was convened to develop a comprehensive state plan and enhance collaboration to more effectively work with enforcement and monitoring systems in the state.

Learning Areas:

Public health or related public policy

Learning Objectives:
Demonstrate state health agency’s role in partnership to address prescription drug abuse

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I 'm a psychologist and public health policy specialist, and the Oklahoma Secretary of Health and Human Services and Commissioner of the Oklahoma State Department of Health. I previously served as the administrator of the federal Substance Abuse and Mental Health Services Administration, an agency within the Health and Human Services Department: overseeing the budget for improving accountability, capacity and effectiveness of the nation’s substance abuse prevention, addictions treatment, and mental health service delivery systems.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4380.0: Public Health and Prescription Overdose Prevention, Monitoring, Enforcement and Treatment